Home NDC 43825-200 Terlivaz
Product NDC 43825-200
11-digit product format 438250200
Labeler code 43825
Product ID 43825-200_0d8cd93f-2403-49ca-a2e4-c72476ff0f72
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Terlipressin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Keenova Hospital Products Inc.
Application NDA022231
Marketing category NDA
Marketing start 2022-09-14
Substance TERLIPRESSIN
Active strength .85 mg/5mL
Pharmacologic classes Vasopressin Receptor Agonist [EPC], Vasopressin Receptor Agonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022231-001 TERLIVAZ TERLIPRESSIN ACETATE EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022231-001 10335452 2037-04-05 U-3711 2023-10-25
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N022231-001 NCE 2027-09-14 N022231-001 ODE-406 2029-09-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 f41ea6bd6efb…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022231-001 TERLIVAZ EQ 0.85MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2022-09-14 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 a72a2bbeb626…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022231-001 10335452 2037-04-05 U-3711 2023-10-25 a50c72e98297…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 54 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Terlivaz
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TERLIPRESSIN .85 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7Z5X49W53P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2612431 Internal RxNorm lookup 2612436 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 43825-200-01 Terlivaz 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 6 43825-200-01 Terlivaz 5 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 5 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43825-200 TERLIVAZ (TERLIPRESSIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.] 5 Current NDC, Legacy NDC, 2 package rows 20240420_3a35b86c-f451-4fac-8499-43019e4da354.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 43825-200-01 43825020001 1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE 2022-09-14 0000-00-00 No No Current